CS191244B2 - Process for the stabilisation of agents containing prostaglandine - Google Patents

Process for the stabilisation of agents containing prostaglandine

Info

Publication number
CS191244B2
CS191244B2 CS752679A CS267975A CS191244B2 CS 191244 B2 CS191244 B2 CS 191244B2 CS 752679 A CS752679 A CS 752679A CS 267975 A CS267975 A CS 267975A CS 191244 B2 CS191244 B2 CS 191244B2
Authority
CS
Czechoslovakia
Prior art keywords
prostaglandine
stabilisation
agents containing
agents
containing prostaglandine
Prior art date
Application number
CS752679A
Other languages
Czech (cs)
English (en)
Inventor
Donald Ch Monkhouse
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of CS191244B2 publication Critical patent/CS191244B2/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS752679A 1974-04-19 1975-04-17 Process for the stabilisation of agents containing prostaglandine CS191244B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US462213A US3927197A (en) 1974-04-19 1974-04-19 Tertiary alcohol stabilized E-series prostaglandins

Publications (1)

Publication Number Publication Date
CS191244B2 true CS191244B2 (en) 1979-06-29

Family

ID=23835600

Family Applications (1)

Application Number Title Priority Date Filing Date
CS752679A CS191244B2 (en) 1974-04-19 1975-04-17 Process for the stabilisation of agents containing prostaglandine

Country Status (23)

Country Link
US (1) US3927197A (nl)
JP (1) JPS5337408B2 (nl)
AR (1) AR213271A1 (nl)
AT (1) AT348130B (nl)
AU (1) AU470631B2 (nl)
BE (1) BE828065A (nl)
BG (1) BG35326A3 (nl)
CA (1) CA1034044A (nl)
CS (1) CS191244B2 (nl)
DD (1) DD119131A5 (nl)
DE (1) DE2516105C3 (nl)
DK (1) DK138161B (nl)
ES (1) ES436613A1 (nl)
FI (1) FI62220C (nl)
FR (1) FR2267760B1 (nl)
GB (1) GB1474852A (nl)
HU (1) HU175405B (nl)
IE (1) IE40829B1 (nl)
IL (1) IL46994A (nl)
LU (1) LU72320A1 (nl)
NL (1) NL158384B (nl)
PH (1) PH11697A (nl)
SE (1) SE428528B (nl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4197257A (en) * 1976-02-04 1980-04-08 The Upjohn Company 6-Keto prostaglandin derivatives
US4169895A (en) * 1976-09-28 1979-10-02 Pfizer Inc. Antisecretory 16,16-dimethyl-17-oxaprostaglandins
US4098805A (en) * 1977-04-11 1978-07-04 The Upjohn Company 9-deoxy-9-methylene-pgf-type amides
ZA831186B (en) * 1982-03-22 1983-11-30 Upjohn Ltd Gelled pge2/triacetin solutions
ZA837627B (en) * 1982-10-15 1984-06-27 Procter & Gamble Storage stable topical pharmaceutical composition containing low dielectric solvents
US5409911A (en) * 1992-09-11 1995-04-25 Merck & Co., Inc. Prostaglandin analog for treating osteoporosis
ES2142409T3 (es) * 1993-10-27 2000-04-16 Upjohn Co Prostaglandina e 1 estabilizada.
HN1996000101A (es) 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis
US6121253A (en) * 1998-11-20 2000-09-19 Merck Frosst Canada & Co. Prostaglandin conjugates for treating or preventing bone disease
US20050203086A1 (en) * 2004-03-04 2005-09-15 Pfizer Inc. Methods of treatment using an EP2 selective receptor agonist
US20100099640A1 (en) * 2007-05-04 2010-04-22 Joannes Geuns Tissue degeneration protection
US9005183B2 (en) * 2007-05-16 2015-04-14 Health Knight, Llc System and method for treating erectile dysfunction
AT515356B1 (de) * 2014-01-30 2015-11-15 Gebro Holding Gmbh Stabile alkoholische Lösung von Alprostadil
RU2020130837A (ru) 2018-02-21 2022-03-21 ЭйАй ТЕРАПЬЮТИКС, ИНК. Комбинационная терапия апилимодом и глутаматергическими агентами

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644638A (en) * 1970-08-24 1972-02-22 American Home Prod Compositions and methods for relieving bronchial spasm with prostanoic acids and esters
US3749800A (en) * 1971-11-01 1973-07-31 Upjohn Co Stable composition for dispensing pge2
US3833725A (en) * 1972-12-08 1974-09-03 Syntex Corp Dialkylated glycol compositions and medicament preparations containing same

Also Published As

Publication number Publication date
LU72320A1 (nl) 1976-03-17
PH11697A (en) 1978-05-24
JPS5337408B2 (nl) 1978-10-09
IE40829B1 (en) 1979-08-29
ES436613A1 (es) 1977-04-16
FI751108A (nl) 1975-10-20
SE428528B (sv) 1983-07-11
DK138161B (da) 1978-07-24
SE7503723L (sv) 1975-10-20
IL46994A0 (en) 1975-06-25
AT348130B (de) 1979-01-25
ATA278875A (de) 1978-06-15
US3927197A (en) 1975-12-16
AR213271A1 (es) 1979-01-15
DE2516105A1 (de) 1975-10-23
GB1474852A (en) 1977-05-25
BE828065A (fr) 1975-10-17
DK167075A (nl) 1975-10-20
JPS50145515A (nl) 1975-11-21
AU470631B2 (en) 1976-03-25
NL7504274A (nl) 1975-10-21
NL158384B (nl) 1978-11-15
CA1034044A (en) 1978-07-04
DE2516105B2 (de) 1981-01-08
IL46994A (en) 1979-10-31
FR2267760A1 (nl) 1975-11-14
BG35326A3 (en) 1984-03-15
FR2267760B1 (nl) 1978-08-04
IE40829L (en) 1975-10-19
HU175405B (hu) 1980-07-28
DE2516105C3 (de) 1982-01-07
FI62220C (fi) 1982-12-10
FI62220B (fi) 1982-08-31
DD119131A5 (nl) 1976-04-12
AU7987775A (en) 1976-03-25
DK138161C (nl) 1979-01-02

Similar Documents

Publication Publication Date Title
GB1536407A (en) Process for the preparation of bis-indolic compounds
CS191244B2 (en) Process for the stabilisation of agents containing prostaglandine
ZA75893B (en) Process for the preparation of carbodiimide-isocyanurate foams
YU135575A (en) Process for obtsining new compounds of the ergoline structure
YU39471B (en) Process for the manufactue of new 1-thiazolylimidazolidinones
ZA757118B (en) Process for the preparation of addition agents
ZA752394B (en) Process for the isolation of gama-l-glutamyl-taurine
CH613193A5 (en) Process for the preparation of novel 2-arylamino-2-imidazoline derivatives
HU171325B (hu) Sposob poluchenija 2-amino-2-imidazolina
IL48062A0 (en) Process for the preparation of metasubstituted halogenophenols
CH613683A5 (en) Process for the preparation of secoprostaglandins
CH614194A5 (en) Process for the preparation of 5-aroyl- and 5-thenoyl-pyrrole compounds
YU36540B (en) Process for the crystallization of furctose
GB1519826A (en) Process for the preparation of 11 - hydroxy - 18 - alkylestrane compounds
YU39940B (en) Process for dehydrohalogenization of 7-halo-or 1,7-dihalo -dihydrocedeinone dialkylketals
ZM11375A1 (en) Process for the preparation of poly-(-n-alkyliminoalanes)
CH612932A5 (en) Process for the preparation of alkylsulphonylphenoxy-propanolamines
ZA75976B (en) Process for the preparation of cis-vincamine
CH611273A5 (en) Process for the preparation of novel 3-oxocyclohex-1-en-1-yl- ureas
EG11656A (en) Process for the preparation of propanolamin derivatives
ZA753469B (en) Process for the preparation of alpha-diol-alpha-dioxo compounds
CH613206A5 (en) Process for the preparation of 1-aminomethyl-6-phenyltriazolobenzodiazepine compounds
HK67179A (en) Process for the preparation of 7-amino-delta3-cephem derivatives
CH613445A5 (en) Process for the preparation of novel N-(p-fluorobenzoylpropyl)-4-piperidylamides
EG11851A (en) Process for preparing of insecticide activators